Browsing Category
General business news
8660 posts
Peel Hunt profit rebound puts PEEL stock back in focus as UK dealmaking recovers
Find out how Peel Hunt’s profit rebound, M&A strength and London IPO weakness could reshape PEEL stock and UK capital markets sentiment.
Bharti Airtel Africa stake consolidation wins shareholder backing as #BHARTIARTL rises
Read how Bharti Airtel’s Africa stake swap could reshape #BHARTIARTL valuation, governance and long-term telecom growth. Find out now!
Lockheed Martin (LMT) wins $514m Space Force contract for GPS IIIF satellites SV23 and SV24
Lockheed Martin (LMT) wins a $514M Space Force contract for GPS IIIF satellites SV23 and SV24, deepening its navigation franchise. Read the full analysis.
Angel One (NSE: ANGELONE) stock hit a high, but is the SEBI settlement a warning under the rally?
Read how Angel One’s ₹4.28 crore SEBI settlement could test #ANGELONE governance credibility near its 52-week high. Find out now!
Fox Corporation stock slides nearly 18% on its $22bn deal to acquire Roku
Fox Corporation (FOXA) stock falls nearly 18 percent on its $22 billion deal to acquire Roku at $160 per share, as investors question the pivot. Full analysis.
AnteoTech sharpens Ultranode 95 battery case as ASX:ADO seeks commercial proof
Find out how AnteoTech’s Ultranode 95 battery validation and Japan diagnostics push could shape ASX:ADO’s next commercial test.
SEPC wins Rs 673cr SAIL order as #SEPC stock jumps despite weak yearly trend
Read how SEPC’s ₹673.32 crore SAIL order could reshape #SEPC sentiment, order book visibility and execution risk. Find out now!
Pennant International stock in focus as PEN wins major Canadian defence software contract
Find out how Pennant International’s Canadian defence software contract could reshape PEN stock, recurring revenue and maritime support demand.
Scotiabank’s Jamaica buyout plan puts BNS Caribbean strategy under sharper focus
Find out how Scotiabank’s Scotia Group Jamaica buyout could reshape BNS capital strategy, Caribbean banking and investor sentiment.
Oscar Health (OSCR) climbs on a Barclays upgrade as the ACA insurer’s margin-recovery thesis meets a stretched valuation
Oscar Health (OSCR) climbs as Barclays upgrades to overweight with a $35 target on a margin-recovery thesis, though the valuation is stretched. Full analysis.